Physician profile
Sheeta Ghosh
NPI 1992738660
$683.09
in general payments reported to CMS, 2019-2025
14 companies · $90.01 in 2025
The $90.01 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $98.83 · 2020: $34.67 · 2021: $31.06 · 2022: $163 · 2023: $170 · 2024: $94.90 · 2025: $90.01.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $355.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $355.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $137.98 | 2020-2025 | Mounjaro |
| Pfizer INC. | $123.17 | 2019-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $86.47 | 2022-2025 | Jardiance, Synjardy, Tradjenta |
| Astrazeneca Pharmaceuticals LP | $74.02 | 2023-2025 | Farxiga, Breztri |
| Abbott Laboratories | $39.86 | 2022-2023 | Freestyle Libre |
| Novo Nordisk INC | $38.66 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $32.75 | 2019-2022 | |
| Philips North America LLC | $30.18 | 2022 | |
| Glaxosmithkline, LLC. | $28.32 | 2023 | Trelegy Ellipta, Shingrix |
| Horizon Therapeutics Plc | $20.37 | 2022 | |
| Cvrx, INC. | $20.20 | 2023 | Barostim Neo System |
| Amgen INC. | $19.19 | 2024 | Repatha |
| Dexcom, INC. | $17.88 | 2022 | |
| Sunovion Pharmaceuticals INC. | $14.04 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sheeta Ghosh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.